Patients Podcasts | pharmaphorum

Podcasts

Patients

Why medical weight loss is more complicated than GLP-1s

A few weeks ago on the pharmaphorum podcast, we discussed the new GLP-1 weight loss drugs and their shake-up effect on the medical weight loss industry.

Patients

Creating behavioural change through incremental, small steps

In this latest episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Sarah Watters, senior consultant at Wellth, a company devoted to improving the health of people wit

Patients

Partnering for holistic care

In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strat

Patients

Mapping the landscape of clinical trial regulation

The COVID-19 pandemic pushed decentralised clinical trials (DCTs) into the mainstream.

Patients

Clinical trial diversity: An update

Editor-in-chief Jonah Comstock welcomes back returning guest Dr Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business.

Patients

Retaining the human quality of healthcare in DTx

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic,

Why medical weight loss is more complicated than GLP-1s

Creating behavioural change through incremental, small steps

Partnering for holistic care

Mapping the landscape of clinical trial regulation

Clinical trial diversity: An update

Retaining the human quality of healthcare in DTx

On GDF-15 neutralisation and cachexia, with CatalYm

Discover a new era of healthcare panel engagement: Grounded ...

Podcasts

Editor's Picks